By ihub_admin, 10 December, 2024 Proud to launch Toripalimab in India, the first immuno-onco drug for RM-NPC
By ihub_admin, 10 December, 2024 Dr. Reddy’s launches Toripalimab to treat rare cancer, India 3rd country to access the drug - Upstox
By ihub_admin, 10 December, 2024 Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma - Pharmacy Times (US B2B trade publication)
